
What We Offer
TMS Therapy
Spravato
A nasal spray aproved in the U.S. as the first and only monotherapy for adults – resistant depression.
Ketamine Therapy
Medication Evaluation & Management
Telepsychiatry
Counseling &
Therapy
Pharmacogenomic Solutions
Concierge Sports Psychiatry
What Makes Us Different

We Accept Most Major Insurances
















What We Believe
Non-Invasive
Therapy
Holistic
Approach
Patient-Centered
Practice
Spravato (esKetamine)
Spravato is the only FDA-approved treatment used as monotherapy or in conjuction with an oral antidepressants for adults with treatment-resistant depression (MDD with inadequate response to at least 2 oral antidepressants of adequate dose and duration)
Spravato is a unique treatment approach that delivers:
- Results as early as 24 hours and out to 28 days.
- Long-term safety and efficacy out to 5 years.


Ketamine Therapy
Ketamine Infusion therapy involves the administration of Ketamine, a dissociative anesthetic, through an intravenous (IV) drip for therapeutic purposes.
Effective in treatment-resistant depression (TRD) and major depressive disorder (MDD).
Rapid reduction in suicidal ideation (often within hours)
TMS Therapy
Refresh TMS uses a magnetic coil to stimulate regions of the brain associated with depression symptoms.
TMS Therapy is now FDA-Cleared for ages 15 and older, as an adjunct (add-on) to your existing therapy. Nearly 10,000 adolescents have been treated with over 300,000 NeuroStar sessions.

